A medical marijuana dispensary called Blüm will open in Reno's Midtown district in April 2016, occupying the building at 1085 S. Virginia St. currently home to the Scotland Yard Spy Shop - a $1.2 million property acquisition that signals growing commercial confidence in Nevada's regulated cannabis market. The move places a dispensary far closer to pedestrian foot traffic and residential blocks than Reno's existing facilities, a deliberate positioning choice by MediFarm, the Nevada-focused subsidiary of publicly traded California company Terra Tech.
A Different Kind of Cannabis Address
The location matters more than it might seem. Most medical marijuana dispensaries in Nevada have operated at a deliberate remove from dense commercial strips and residential neighborhoods - partly by regulatory design, partly by the instinct of early operators trying to avoid friction. Reno's Sierra Wellness Connection and Sparks' Silver State Relief both reflect that cautious geography. Blüm, by contrast, is dropping into one of Reno's more walkable, visible corridors.
Terra Tech CEO Derek Peterson frames this as intentional community integration rather than provocation. "We didn't run across any concerns about the location," he said, noting that the company makes a practice of consulting neighboring businesses before opening. Whether that process fully attenuates neighborhood skepticism remains to be seen - but Midtown Reno, with its mix of independent shops, restaurants, and residential density, is arguably a more forgiving environment for that experiment than a suburban strip mall would be.
The Scotland Yard Spy Shop isn't disappearing, for what it's worth. Owners David and Debbie Currier sold their building for roughly $1.2 million and picked up a property across the street for about half that figure - a transaction that worked out reasonably well for them, and that cleared the way for the dispensary without displacing a business entirely.
Nevada's Regulatory Architecture Made This Possible
Peterson is direct about why Terra Tech targeted Nevada. The state's medical marijuana regulations are structurally permissive in ways that matter to multi-state operators: applicants don't need to be Nevada residents, and the state offers multi-state reciprocity, meaning card-holding patients from other states can legally purchase here. That last provision alone makes Nevada unusual. Most states with medical marijuana programs treat out-of-state cards as legally irrelevant within their borders.
The result is a regulatory framework that reads less like a public health gatekeeping system and more like an invitation to build a functioning market - which is precisely the signal that draws publicly traded companies with existing infrastructure in other states. Terra Tech already operates dispensaries elsewhere; Nevada is an expansion, not a debut.
Blüm will initially source its product from licensed Nevada cultivators, while MediFarm builds out its own cultivation facility - a vertical integration model that, once complete, gives the company control from plant to sale. That kind of supply chain ownership is increasingly standard among larger cannabis operators, and it carries obvious margin advantages over pure retail.
The Recreational Variable Looming Over Every Calculation
Here's the thing: nobody in the cannabis industry in Nevada is operating purely on the medical market's fundamentals right now. A ballot measure on recreational marijuana legalization is expected to go before Nevada voters in November 2016, and the arithmetic changes substantially if it passes.
Peterson doesn't obscure his thinking. "I think Nevada's potential size of the recreational market may be number two or three in the country," he said. The reasoning is fairly straightforward - Nevada draws tens of millions of visitors annually, particularly to Las Vegas, and the state's multi-state reciprocity framework already demonstrates a willingness to serve non-resident consumers. A recreational market in that context would not behave like Colorado's or Oregon's, which are primarily serving their own populations. Nevada's would be, in large part, a tourism-driven market. That's a structurally different revenue proposition.
Terra Tech is already building a dispensary near the Las Vegas Strip and has two more planned for unincorporated Clark County. The Northern Nevada footprint - meaning Blüm in Reno - rounds out a statewide positioning strategy that clearly anticipates the recreational vote going favorably.
Hiring and Timeline
Hiring events are scheduled to begin in January, with the dispensary targeting an April 2016 opening. Peterson said the company will prioritize local hires, with particular attention to military veterans - a hiring emphasis that has become something of an industry signal, partly genuine and partly a way of softening public perception in communities where dispensaries still generate unease.
Whether Blüm's Midtown location ultimately reads as a sign of cannabis normalization in Reno or as a flash point for neighborhood debate probably depends on how the first few months go. Dispensaries in walkable urban corridors have, in other states, tended to generate more controversy in the anticipation than in the reality. Foot traffic normalizes quickly; the building just becomes part of the block. That may prove true here too - or Midtown may offer some friction that a more isolated address would have avoided. April will answer the question either way.
